New England Compounding Center Issues Voluntary Recall Of All Products

FOR IMMEDIATE RELEASE – The pharmaceutical company known as New England Compounding Pharmacy, Inc., which is a subsidiary of New England Compounding Center (NECC), announced on October 6, 2012 that it had issued a recall of all of its products that are currently in circulation.  The products were compounded in and distributed from its facility in Framingham, Massachusetts.  This measure is being undertaken out of an abundance of caution due to the potential risk of contamination and in conjunction with an investigation which is being conducted by the US FDA, the Centers for Disease Control and Prevention, and the Massachusetts Board of Registration in Pharmacy.  It is worth noting that the FDA has previously issued guidance for medical professionals that all products by the New England Compounding Center should be secured and retained.  While there’s no indication during this period of any contamination in other New England Compounding Center products, this recall is being undertaken as a precautionary measure.  Products from the NECC can be identified by brand markings which notify healthcare professionals and consumers by its name or acronym (NECC), or the company logo.  Check for a complete list of all products that have been subject to the recall.

The NECC is notifying its consumers of this recall by fax.  Clinics, healthcare providers and hospitals that have these products which are being recalled should stop their use immediately, retain and secure the products, and follow the instructions contained in the fax.

Learn more about the contamination here.